Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate. (2021)
Attributed to:
Exploitation of a Pharmacological 'Master Switch' to Probe the K+ Channel Selectivity Filter Gating Mechanism
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1085/jgp.202012812
PubMed Identifier: 34032848
Publication URI: http://europepmc.org/abstract/MED/34032848
Type: Journal Article/Review
Volume: 153
Parent Publication: The Journal of general physiology
Issue: 8
ISSN: 0022-1295